Spotlight On... Texas team develops Zika mouse model

A team at the University of Texas Medical Branch has developed a mouse model to test Zika vaccines and treatments after three weeks, cutting down the usual process from a timeline of multiple months, the researchers said. Scott Weaver, UTMB virologist, told Reuters the team will run tests attempting to produce sexual transmission of Zika in the mice. The mouse model is anticipated to be integral in the search for a Zika vaccine, Weaver explained. The study was published in American Journal of Tropical Medicine and Hygiene. Report

> Researchers published findings in the journal Pediatrics showing that breastfeeding and new vaccines have lowered the rate of ear infections in infants. Report

> The Sabin Vaccine Institute named Amy Finan, currently an SVP at biotech industry group BIO, its next CEO, effective April 18. Release

Webinar

Bioavailability Enhancement – Industry Insights, Key Challenges & Advanced Development Solutions

Join this webcast on Tuesday, June 16 as experts present the exclusive survey findings and introduce innovative scalable drug delivery technologies proven to address the industry’s growing need for improving solubility and enhancing bioavailability.

> Dengvaxia, Sanofi Pasteur's new dengue vaccine, was named the "Vaccine Breakthrough of 2016" at an awards event in Singapore. Release

And Finally... The Tribeca Film Festival's decision to pull antivaccination movie "Vaxxed: From Cover-Up to Catastrophe" triggered both support and outrage. Report (sub. req.)

Suggested Articles

Moderna is entering an important time, its CEO says. And the company is doing so with a new finance chief from Big Biotech.

Not wanting to be left behind in the COVID-19 vaccine race, Europe is stepping up its efforts secure supplies if any immunizations prove effective.

The Trump administration has selected five COVID-19 vaccines for Operation Warp Speed, the NYT reports, with Big Pharma dominating the list.